Novick Steven (24 results)

Condition: As New. Unread book in perfect condition.

Condition: New.

Condition: New.

Condition: New.

Condition: New.

Condition: New. 1st edition NO-PA16APR2015-KAP.

Paperback. Condition: New. Drug development is an iterative process. The recent publications of regulatory guidelines further entail a lifecycle approach. Blending data from disparate sources, the Bayesian approach provides a flexible framework for drug development. Despite its advantages, the uptake of Bayesian methodologies is lagging behind in the field of pharmaceutical development.Written specifically for pharmaceutical practitioners, Bayesian Analysis with R for Drug Development: Concepts, Algorithms, and Case Studies, describes a wide range of Bayesian applications to problems throughout pre-clinical, clinical, and Chemistry, Manufacturing, and Control (CMC) development. Authored by two seasoned statisticians in the pharmaceutical industry, the book provides detailed Bayesian solutions to a broad array of pharmaceutical problems.Features Provides a single source of information on Bayesian statistics for drug development Covers a wide spectrum of pre-clinical, clinical, and CMC topics Demonstrates proper Bayesian applications using real-life examples Includes easy-to-follow R code with Bayesian Markov Chain Monte Carlo performed in both JAGS and Stan Bayesian software platforms Offers sufficient background for each problem and detailed description of solutions suitable for practitioners with limited Bayesian knowledgeHarry Yang, Ph.D., is Senior Director and Head of Statistical Sciences at AstraZeneca. He has 24 years of experience across all aspects of drug research and development and extensive global regulatory experiences. He has published 6 statistical books, 15 book chapters, and over 90 peer-reviewed papers on diverse scientific and statistical subjects, including 15 joint statistical works with Dr. Novick. He is a frequent invited speaker at national and international conferences. He also developed statistical courses and conducted training at the FDA and USP as well as Peking University.Steven Novick, Ph.D., is Director of Statistical Sciences at AstraZeneca. He has extensively contributed statistical methods to the biopharmaceutical literature. Novick is a skilled Bayesian computer programmer and is frequently invited to speak at conferences, having developed and taught courses in several areas, including drug-combination analysis and Bayesian methods in clinical areas. Novick served on IPAC-RS and has chaired several national statistical conferences.…

Condition: As New. Unread book in perfect condition.

Condition: New. In English.

Condition: New.

Hardcover. Condition: Very Good. No Jacket. 1st Edition. 2019.Hardcover.Very good condition.310 pages.Ships from Japan.Usually ships in 1-2 working days.

Paperback. Condition: Brand New. 310 pages. 9.18x6.12x0.74 inches. In Stock.

Hardcover. Condition: Very Good. Dust Jacket Condition: Very Good. 2017 Brill hardcover edition. Unread copy in very good condition. From the cover: The eighteen studies in this volume in honor of Moshe Bernstein on the occasion of his 70th birthday mostly engage with Jewish scriptural interpretation, the principal theme of Bernstein's own research career as expressed in his collected essays, Reading and Re-Reading Scripture at Qumran (Brill, 2013). The essays develop a variety of aspects of scriptural interpretation. Although many of them are chiefly concerned with the Dead Sea Scrolls, the significant contribution of the volume as a whole is the way that even those studies are associated with others that consider the broader context of Jewish scriptural interpretation in late antiquity. As a result, a wider frame of reference for scriptural interpretation impacts upon how scripture was read and re-read in the scrolls from Qumran. Contents: Abbreviations Bibliography of the Writings of Moshe J. Bernstein List of Contributors Introduction: Binyamin Y. Goldstein, Michael Segal, and George J. Brooke 1 Writing a Descriptive Grammar of 4Q252: The Noun Phrase: Martin G. Abegg, Jr. 2 A Newly Discovered Interpretation of Isaiah 40:12-13 in the Songs of the Sage: Joseph L. Angel 3 Missing and Misplaced? Omission and Transposition in the Book of Jubilees: Abraham J. Berkovitz 4 Hot at Qumran, Cold in Jerusalem: A Reconsideration of Some Late Second Temple Period Attitudes to the Scriptures and their Interpretation: George J. Brooke 5 The Interpretation of Ezekiel in the Hodayot: Devorah Dimant 6 The Quantification of Religious Obligation in Second Temple Judaism - And Beyond: Yaakov Elman and Mahnaz Moazami 7 The Temple Scroll as Rewritten Bible: When Genres Bend: Steven D. Fraade 8 Hellenism and Hermeneutics: Did the Qumranites and Sadducees Use qal va-homer Arguments?: Richard Hidary 9 The Puzzle of Torah and the Qumran Wisdom Texts: John I. Kampen 10 An Interpretative Reading in the Isaiah Scroll of Rabbi Meir: Armin Lange 11 'Wisdom Motifs' in the Compositional Strategy of the Genesis Apocryphon (1Q20) and Other Aramaic Texts from Qumran: Daniel A. Machiela 12 On the Paucity of Biblical Exemplars in Sectarian Texts: Tzvi Novick 13 The Mikhbar in the Temple Scroll: Lawrence H. Schiffman 14 Harmonization and Rewriting of Daniel 6 from the Bible to Qumran: Michael Segal 15 The Textual Base of the Biblical Quotations in Second Temple Compositions: Emanuel Tov 16 From Genesis to Exodus in the Book of Jubilees: James C. VanderKam 17 Deuteronomy in the Temple Scroll and Its Use in the Textual Criticism of Deuteronomy: Sidnie White Crawford 18 Exegesis, Ideology, and Literary History in the Temple Scroll: The Case of the Temple Plan: Molly M. Zahn 19 The Neglected Oaths Passage (CD IX:8-12): The Elusive, Allusive Meaning: Shlomo Zuckier Index of Ancient Sources Index of Modern Authors.…

Paperback. Condition: New. Drug development is an iterative process. The recent publications of regulatory guidelines further entail a lifecycle approach. Blending data from disparate sources, the Bayesian approach provides a flexible framework for drug development. Despite its advantages, the uptake of Bayesian methodologies is lagging behind in the field of pharmaceutical development.Written specifically for pharmaceutical practitioners, Bayesian Analysis with R for Drug Development: Concepts, Algorithms, and Case Studies, describes a wide range of Bayesian applications to problems throughout pre-clinical, clinical, and Chemistry, Manufacturing, and Control (CMC) development. Authored by two seasoned statisticians in the pharmaceutical industry, the book provides detailed Bayesian solutions to a broad array of pharmaceutical problems.Features Provides a single source of information on Bayesian statistics for drug development Covers a wide spectrum of pre-clinical, clinical, and CMC topics Demonstrates proper Bayesian applications using real-life examples Includes easy-to-follow R code with Bayesian Markov Chain Monte Carlo performed in both JAGS and Stan Bayesian software platforms Offers sufficient background for each problem and detailed description of solutions suitable for practitioners with limited Bayesian knowledgeHarry Yang, Ph.D., is Senior Director and Head of Statistical Sciences at AstraZeneca. He has 24 years of experience across all aspects of drug research and development and extensive global regulatory experiences. He has published 6 statistical books, 15 book chapters, and over 90 peer-reviewed papers on diverse scientific and statistical subjects, including 15 joint statistical works with Dr. Novick. He is a frequent invited speaker at national and international conferences. He also developed statistical courses and conducted training at the FDA and USP as well as Peking University.Steven Novick, Ph.D., is Director of Statistical Sciences at AstraZeneca. He has extensively contributed statistical methods to the biopharmaceutical literature. Novick is a skilled Bayesian computer programmer and is frequently invited to speak at conferences, having developed and taught courses in several areas, including drug-combination analysis and Bayesian methods in clinical areas. Novick served on IPAC-RS and has chaired several national statistical conferences.…

Condition: As New. Unread book in perfect condition.

Condition: As New. Unread book in perfect condition.

Condition: New.

Condition: New.

Condition: New.

Condition: New.

Condition: New.

Condition: New. Harry Yang is Senior Director and Head of Statistical Sciences at MedImmune. He has 24 years of experience across all aspects of drug research and development and extensive global regulatory experiences. He has published six statistical .

Hardcover. Condition: New. NEW. SHIPS FROM MULTIPLE LOCATIONS. book.

Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Harry Yang is Senior Director and Head of Statistical Sciences at MedImmune. He has 24 years of experience across all aspects of drug research and development and extensive global regulatory experiences. He has published six statistical .…